Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 36

1.

Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.

Myint YY, Miyakawa K, Naito M, Shultz LD, Oike Y, Yamamura K, Takahashi K.

Am J Pathol. 1999 Feb;154(2):553-66.

2.

Vascular endothelial growth factor (VEGF) and its receptors.

Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z.

FASEB J. 1999 Jan;13(1):9-22. Review.

PMID:
9872925
3.

Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M.

Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54.

4.

Colony-stimulating factor-1 stimulates the fusion process in osteoclasts.

Amano H, Yamada S, Felix R.

J Bone Miner Res. 1998 May;13(5):846-53.

5.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ.

Cell. 1998 Apr 17;93(2):165-76.

7.

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T.

Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3597-602.

8.

Expressions of PDGF receptor alpha, c-Kit and Flk1 genes clustering in mouse chromosome 5 define distinct subsets of nascent mesodermal cells.

Kataoka H, Takakura N, Nishikawa S, Tsuchida K, Kodama H, Kunisada T, Risau W, Kita T, Nishikawa SI.

Dev Growth Differ. 1997 Dec;39(6):729-40.

PMID:
9493833
10.

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M.

Cell Growth Differ. 1996 Feb;7(2):213-21.

11.
12.

Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.

Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, Marmé D.

Blood. 1996 Apr 15;87(8):3336-43.

13.

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.

Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O'Shea KS, Powell-Braxton L, Hillan KJ, Moore MW.

Nature. 1996 Apr 4;380(6573):439-42.

14.

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele.

Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawling J, Moons L, Collen D, Risau W, Nagy A.

Nature. 1996 Apr 4;380(6573):435-9.

PMID:
8602241
15.

Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M.

Sudo T, Nishikawa S, Ogawa M, Kataoka H, Ohno N, Izawa A, Hayashi S, Nishikawa S.

Oncogene. 1995 Dec 21;11(12):2469-76.

PMID:
8545103
16.
17.

Delayed hematopoietic development in osteopetrotic (op/op) mice.

Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I.

J Exp Med. 1993 Jan 1;177(1):237-42.

18.
19.

Supplemental Content

Support Center